TLDR:
- 2Flo Ventures has appointed Jones-Burton as a partner.
- Jones-Burton previously held positions at Otsuka Pharmaceuticals.
2Flo Ventures, a venture capital firm, has announced the appointment of Jones-Burton as a partner. Jones-Burton brings with her a wealth of experience, having previously served as the vice president of global clinical development and head of nephrology at Otsuka Pharmaceuticals. This new addition to the team is expected to bring diversity and valuable expertise to 2Flo Ventures.
The move comes as part of the firm’s ongoing efforts to strengthen its team and expand its reach in the venture capital industry. With Jones-Burton’s background in the pharmaceutical sector, she is expected to provide valuable insights and strategic guidance to the firm’s portfolio companies.
Overall, the appointment of Jones-Burton as a partner at 2Flo Ventures signifies a strategic move by the firm to diversify its leadership team and enhance its capabilities in the competitive venture capital landscape. This development is a positive step towards achieving the firm’s long-term growth and success in the industry.
